Top Buy
| Security | Buy | Sell | Buy (1W) ▲ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| PharmAust Ltd. | 1 | 0 | 0 | 0 | €0.083 | - | - |
| Codexis Inc. | 5 | 2 | 0 | 0 | €3.23 | €8.36 | 158.675% |
| Adocia | 1 | 0 | 0 | 0 | €9.20 | €20.00 | 117.391% |
| Horizon Pharma plc | 5 | 0 | 0 | 0 | €110.40 | - | - |
| Agios Pharmaceuticals Inc. | 6 | 0 | 0 | 0 | €31.40 | €38.99 | 24.168% |
| Esperion Therapeutis.Inc. | 15 | 0 | 1 | 0 | €1.96 | €8.55 | 336.217% |
| Natural Alternat. | 19 | 1 | 1 | 0 | €5.95 | - | - |
| Trinity Biotech ADR | 24 | 0 | 1 | 0 | €0.41 | - | - |
| PTC Therapeutics Inc. | 15 | 7 | 1 | 2 | €33.80 | €41.81 | 23.710% |
| Verastem Inc. | 10 | 0 | 1 | 0 | €4.02 | €24.63 | 512.806% |
| Evolus Inc | 10 | 0 | 1 | 0 | €11.10 | €20.46 | 84.344% |
| Intra-Cellular Therapies Inc. | 25 | 0 | 1 | 0 | €60.50 | €79.55 | 31.495% |
| Abbott Laboratories | 17 | 0 | 1 | 0 | €95.51 | €116.71 | 22.200% |
| Compugen Ltd. | 4 | 2 | 1 | 0 | €2.25 | €3.69 | 64.169% |
| Purple Biotech Ltd. ADR | 6 | 0 | 1 | 0 | €0.69 | €9.21 | 1234.565% |
| Iovance Biotherapeutics Inc. | 21 | 3 | 1 | 0 | €9.28 | €25.20 | 171.640% |
| MacroGenics Inc. | 13 | 0 | 1 | 0 | €4.18 | €12.42 | 196.957% |
| Vertex Pharmaceuticals Inc. | 47 | 2 | 1 | 0 | €424.50 | €425.79 | 0.303% |
| United Therapeutics | 19 | 0 | 1 | 0 | €253.30 | €287.40 | 13.463% |
| Halozyme Therapeutics Inc. | 15 | 0 | 1 | 0 | €40.40 | €47.17 | 16.757% |
| Cara Therapeutics Inc. | 11 | 1 | 1 | 0 | €0.68 | €4.62 | 580.560% |
| G1 Therapeutics | 17 | 1 | 2 | 0 | €3.77 | €10.05 | 166.968% |
| Biogen Inc. | 49 | 1 | 2 | 0 | €201.00 | €293.57 | 46.056% |
| Novavax Inc. | 8 | 1 | 4 | 0 | €14.11 | €27.38 | 94.051% |
| Cytokinetics Inc. | 31 | 1 | 4 | 0 | €44.60 | €83.13 | 86.393% |